Literature DB >> 23134323

Chrysin: a histone deacetylase 8 inhibitor with anticancer activity and a suitable candidate for the standardization of Chinese propolis.

Li-Ping Sun1, Ai-Ling Chen, Hsiao-Chiao Hung, Yin-Huan Chien, Jing-Shi Huang, Chung-Yang Huang, Yue-Wen Chen, Chia-Nan Chen.   

Abstract

Chinese propolis (CP) is a natural product collected by honeybees and a health food raw material. Previous studies have shown that CP exhibits a broad spectrum of biological activities including anticancer, antioxidant, antibacterial, anti-inflammatory, and antiviral activities. The focuses of the present study were the standardization of CP and the possible mechanisms of its active anticancer ingredients. Nine samples of CP were collected from different locations in China. Analyses of the CP samples revealed that all 9 had similar chemical compositions. Parameters analyzed included the CP extract dry weight, total phenolic content, and DPPH free radical scavenging activities. The active anticancer ingredient was isolated, characterized against human MDA-MB-231 breast cancer cells, and identified as chyrsin, a known potent anticancer compound. Chrysin is present at high levels in all 9 of the CP samples, constituting approximately 2.52% to 6.38% of the CP extracts. However, caffeic acid phenethyl ester (CAPE), another potent active ingredient is present in low levels in 9 samples of CP, constituting approximately 0.08% to 1.71% of the CP extracts. Results from analyses of enzymatic activity indicated that chrysin is a histone deacetylase inhibitor (HDACi) and that it markedly inhibited HDAC8 enzymatic activity (EC(50) = 40.2 μM). In vitro analyses demonstrated that chrysin significantly suppressed cell growth and induced differentiation in MDA-MB-231 cells. In a xenograft animal model (MDA-MB-231 cells), orally administered chrysin (90 mg/kg/day) significantly inhibited tumor growth. Despite the geographical diversity of the 9 samples' botanical origins, their chemical compositions and several analyzed parameters were similar, suggesting that CP is standardized, with chrysin being the major active ingredient. Overall, in vitro and in vivo data indicated that chrysin is an HDAC8 inhibitor, which can significantly inhibit tumor growth. Data also suggested that chrysin might represent a suitable candidate for standardization of CP.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23134323     DOI: 10.1021/jf303261r

Source DB:  PubMed          Journal:  J Agric Food Chem        ISSN: 0021-8561            Impact factor:   5.279


  23 in total

1.  Chrysin and its emerging antineoplastic effects.

Authors:  E R Kasala; L N Bodduluru; C C Barua
Journal:  Cancer Gene Ther       Date:  2016-01       Impact factor: 5.987

Review 2.  Cellular analysis of the action of epigenetic drugs and probes.

Authors:  Mirjam Hau; Fides Zenk; A Ganesan; Nicola Iovino; Manfred Jung
Journal:  Epigenetics       Date:  2017-01-10       Impact factor: 4.528

Review 3.  Anticancer potential of the histone deacetylase inhibitor-like effects of flavones, a subclass of polyphenolic compounds: a review.

Authors:  Prabhat Singh; Raghuvir Singh Tomar; Srikanta Kumar Rath
Journal:  Mol Biol Rep       Date:  2015-06-02       Impact factor: 2.316

Review 4.  Propolis: An update on its chemistry and pharmacological applications.

Authors:  Rajib Hossain; Cristina Quispe; Rasel Ahmed Khan; Abu Saim Mohammad Saikat; Pranta Ray; Damira Ongalbek; Balakyz Yeskaliyeva; Divya Jain; Antonella Smeriglio; Domenico Trombetta; Roghayeh Kiani; Farzad Kobarfard; Naheed Mojgani; Parvaneh Saffarian; Seyed Abdulmajid Ayatollahi; Chandan Sarkar; Mohammad Torequl Islam; Dılhun Keriman; Arserim Uçar; Miquel Martorell; Antoni Sureda; Gianfranco Pintus; Monica Butnariu; Javad Sharifi-Rad; William C Cho
Journal:  Chin Med       Date:  2022-08-26       Impact factor: 4.546

5.  Propolis and its Active Component, Caffeic Acid Phenethyl Ester (CAPE), Modulate Breast Cancer Therapeutic Targets via an Epigenetically Mediated Mechanism of Action.

Authors:  Coral Omene; Matko Kalac; Jing Wu; Enrica Marchi; Krystyna Frenkel; Owen A O'Connor
Journal:  J Cancer Sci Ther       Date:  2013-10-21

6.  Effect of Ethanol/Water Solvents on Phenolic Profiles and Antioxidant Properties of Beijing Propolis Extracts.

Authors:  Chunli Sun; Zhengshuang Wu; Ziyan Wang; Hongcheng Zhang
Journal:  Evid Based Complement Alternat Med       Date:  2015-08-17       Impact factor: 2.629

Review 7.  Propolis: A Complex Natural Product with a Plethora of Biological Activities That Can Be Explored for Drug Development.

Authors:  Ricardo Silva-Carvalho; Fátima Baltazar; Cristina Almeida-Aguiar
Journal:  Evid Based Complement Alternat Med       Date:  2015-05-27       Impact factor: 2.629

8.  Histone deacetylase inhibitory effect of Brazilian propolis and its association with the antitumor effect in Neuro2a cells.

Authors:  Shinobu Ishiai; Wataru Tahara; Etsuko Yamamoto; Rindai Yamamoto; Kaoru Nagai
Journal:  Food Sci Nutr       Date:  2014-06-02       Impact factor: 2.863

9.  NBM-T-L-BMX-OS01, Semisynthesized from Osthole, Is a Novel Inhibitor of Histone Deacetylase and Enhances Learning and Memory in Rats.

Authors:  Ying-Chen Yang; Chia-Nan Chen; Carol-Imei Wu; Wei-Jan Huang; Tsun-Yung Kuo; Ming-Chung Kuan; Tung-Hu Tsai; Jing-Shi Huang; Chung-Yang Huang
Journal:  Evid Based Complement Alternat Med       Date:  2013-03-28       Impact factor: 2.629

10.  Antitumor Activity of Chinese Propolis in Human Breast Cancer MCF-7 and MDA-MB-231 Cells.

Authors:  Hongzhuan Xuan; Zhen Li; Haiyue Yan; Qing Sang; Kai Wang; Qingtao He; Yuanjun Wang; Fuliang Hu
Journal:  Evid Based Complement Alternat Med       Date:  2014-05-22       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.